Results 231 to 240 of about 313,710 (255)

The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review

European Journal of Medicinal Chemistry, 2018
Chengyuan Liang, Suresh Thareja, Xiaodong Ren   +2 more
exaly  

Tyrosine kinase inhibitors

2007
LIM JONGWON, ORTEGA GABARDA ANA ESTHER
openaire   +2 more sources

Formation of reactive metabolites and management of tyrosine kinase inhibitor-induced hepatotoxicity: a literature review

Expert Opinion on Drug Metabolism and Toxicology, 2015
Han Kiat Ho, Yi Ling Teo
exaly  

Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors

Annals of Oncology, 2015
Giuseppe Giaccone, D R Camidge, B T Li
exaly  

TYROSINE KINASE INHIBITORS

2008
KIM ANNETTE S, ZHANG XUFANG
openaire   +2 more sources

Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances

Journal of Drug Targeting, 2016
Mohammad Hojjat-Farsangi
exaly  

INHIBITORS OF BRUTON'S TYROSINE KINASE

2008
HONIGBERG LEE, VERNER ERIK J, BUGGY JOSEPH J, LOURY DAVID J, CHEN WEI   +4 more
openaire   +16 more sources

BRUTON'S TYROSINE KINASE INHIBITORS

2011
ERLANSON DANIEL A, MARCOTTE DOUG, KUMARAVEL GNANASAMBANDAM, FAN JUNFA, WANG DEPING, CUERVO JULIO H, SILVIAN LAURA, POWELL NOEL, BUI MINNA, HOPKINS BRIAN T, TAVERAS ART, GUAN BING, CONLON PATRICK, ZHONG MIN, JENKINS TRACY J, SCOTT DANIEL, LUGOVSKOY ALEXEY A   +16 more
openaire   +8 more sources

Bruton's tyrosine kinase inhibitors

2022
LIAO XIBIN, LV YUBIN
openaire   +2 more sources

Tyrosine kinase inhibitors

2014
openaire   +4 more sources